Discovery Holds Promise for 'Bubble Boy’ Patients

December 07, 2013

An international study led by Dana-Farber Cancer Institute and Boston Children's Hospital has shown that a new type of gene therapy may help boys with a fatal immune disorder commonly known as “bubble boy” disease, the Boston Business Journal reports. A new delivery method for the gene therapy is designed to prevent patients from developing leukemia, a side effect that emerged during a similar trial 10 years ago, and doused hopes for the treatment.

Read the full story. Read the news release.

Media Inquiries

Irene Sege
Senior Media Relations Specialist
irene.sege@childrens.harvard.edu
1-617-919-7379

Follow Us!

Stay updated on our latest news and developments by following us on Twitter.

Twitter Logo